Dixon D - Search Results

1

Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice.

Fryer RM, Rakestraw PA, Nakane M, Dixon D, Banfor PN, Koch KA, Wu-Wong JR, Reinhart GA. Fryer RM, et al. Among authors: dixon d. Nephron Physiol. 2007;106(4):p76-81. doi: 10.1159/000104875. Epub 2007 Jul 2. Nephron Physiol. 2007. PMID: 17622742

2

Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification.

Wu-Wong JR, Noonan W, Ma J, Dixon D, Nakane M, Bolin AL, Koch KA, Postl S, Morgan SJ, Reinhart GA. Wu-Wong JR, et al. Among authors: dixon d. J Pharmacol Exp Ther. 2006 Jul;318(1):90-8. doi: 10.1124/jpet.106.101261. Epub 2006 Apr 7. J Pharmacol Exp Ther. 2006. PMID: 16603671

3

Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells.

Wu-Wong JR, Nakane M, Ma J, Dixon D, Gagne G. Wu-Wong JR, et al. Among authors: dixon d. Leuk Lymphoma. 2006 Apr;47(4):727-32. doi: 10.1080/10428190500398898. Leuk Lymphoma. 2006. PMID: 16690532

4

Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.

Noonan W, Koch K, Nakane M, Ma J, Dixon D, Bolin A, Reinhart G. Noonan W, et al. Among authors: dixon d. Nephrol Dial Transplant. 2008 Dec;23(12):3824-30. doi: 10.1093/ndt/gfn375. Epub 2008 Jul 20. Nephrol Dial Transplant. 2008. PMID: 18644798

5

Differential effects of Vitamin D analogs on bone formation and resorption.

Nakane M, Fey TA, Dixon DB, Ma J, Brune ME, Li YC, Wu-Wong JR. Nakane M, et al. J Steroid Biochem Mol Biol. 2006 Jan;98(1):72-7. doi: 10.1016/j.jsbmb.2005.07.007. Epub 2005 Oct 20. J Steroid Biochem Mol Biol. 2006. PMID: 16242929

6

Effects of human plasma proteins on endothelin binding and function.

Wu-Wong JR, Dixon DB, Opgenorth TJ. Wu-Wong JR, et al. Among authors: dixon db. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S164-8. doi: 10.1097/00005344-199800001-00047. J Cardiovasc Pharmacol. 1998. PMID: 9595428

7

Dissociation characteristics of endothelin ETA receptor agonists and antagonists.

Wu-Wong JR, Chiou WJ, Dixon DB, Opgenorth TJ. Wu-Wong JR, et al. Among authors: dixon db. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S380-4. J Cardiovasc Pharmacol. 1995. PMID: 8587421

8

Endothelin receptor antagonists: effect of serum albumin on potency and comparison of pharmacological characteristics.

Wu-Wong JR, Dixon DB, Chiou WJ, Opgenorth TJ. Wu-Wong JR, et al. Among authors: dixon db. J Pharmacol Exp Ther. 1997 May;281(2):791-8. J Pharmacol Exp Ther. 1997. PMID: 9152387

9

Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor.

Wu-Wong JR, Dixon DB, Chiou WJ, Dayton BD, Novosad EI, Adler AL, Wessale JL, Calzadilla SV, Hernandez L, Marsh KC, Liu G, Szczepankiewicz B, von Geldern TW, Opgenorth TJ. Wu-Wong JR, et al. Among authors: dixon db. Eur J Pharmacol. 1999 Feb 5;366(2-3):189-201. doi: 10.1016/s0014-2999(98)00891-7. Eur J Pharmacol. 1999. PMID: 10082200

10

Azole endothelin antagonists. 2. Structure-activity studies.

von Geldern TW, Kester JA, Bal R, Wu-Wong JR, Chiou W, Dixon DB, Opgenorth TJ. von Geldern TW, et al. Among authors: dixon db. J Med Chem. 1996 Feb 16;39(4):968-81. doi: 10.1021/jm950592+. J Med Chem. 1996. PMID: 8632420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,035 results

Search Page

Filters